Stada UK Head On COVID-19 Impact, Local Growth Strategy And OTC Brand Innovation
Executive Summary
Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.
You may also be interested in...
Top 10 UK OTC Marketing Stories 2020: Digital Health And Probiotics Lead The Way
HBW Insight's countdown of the top-10 most read UK OTC marketing stories in 2020 includes launches and campaigns from consumer health players such as Sanofi, J&J, GSK and Bayer, amongst others.
Stada's Nature’s Aid Submits CBD Novel Food Application
HBW Insight speaks exclusively to Chris Morrey, CEO of Stada's UK Nature's Aid subsidiary, about the company's experiments with CBD and its recently submitted EU novel food application.
Stada Grabs GSK Brands In Key EU Markets
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.